Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
2,083,186
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
234,158
-
Shares change
-
-19,051
-
Total reported value, excl. options
-
$283,214
-
Value change
-
-$34,112
-
Number of buys
-
7
-
Number of sells
-
8
-
Price
-
$1.21
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) as of Q2 2025
As of 30 Jun 2025 Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 234,158 shares of stock of the company.
Largest 10 holders included AdvisorShares Investments LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Virtu Financial LLC, MORGAN STANLEY, Tower Research Capital LLC (TRC), BlackRock, Inc., SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/.
This table shows 14 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.